CD90 is a specific surface marker highly expressed in glioma-associated mesenchymal stem cells [70] and drives glioma progression through SRC-dependent mechanisms increasing proliferation, migration, and adhesion [71]. This evidence concerns the gene SRC and central nervous system cancer.